# Justyna Amelio

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/justyna-amelio/

## Facts

| Field | Value |
| --- | --- |
| Citations | 754 |
| Field | Sarcoma Diagnosis and Treatment |
| h-index | 13 |
| i10-index | 13 |
| Last Known Institution | GlaxoSmithKline (United Kingdom) |
| OpenAlex ID | https://openalex.org/A5067531937 |
| ORCID iD | 0000-0002-3130-5101 |
| Works | 32 |

## Researcher papers

- [Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression](https://scholariq.org/papers/systemic-lupus-erythematosus-lupus-nephritis-and-end-stage-renal-disease-a/)
- [Systematic review and meta-analysis on the proportion of patients with breast cancer who develop bone metastases](https://scholariq.org/papers/systematic-review-and-meta-analysis-on-the-proportion-of-patients-with-breast/)
- [Epidemiology of cutaneous melanoma in Sweden—Stage‐specific survival and rate of recurrence](https://scholariq.org/papers/epidemiology-of-cutaneous-melanoma-in-sweden-stage-specific-survival-and-rate-of/)
- [Population-based study of giant cell tumor of bone in Sweden (1983–2011)](https://scholariq.org/papers/population-based-study-of-giant-cell-tumor-of-bone-in-sweden-1983-2011/)
- [Incidence Trends in the Diagnosis of Giant Cell Tumor of Bone in Sweden Since 1958](https://scholariq.org/papers/incidence-trends-in-the-diagnosis-of-giant-cell-tumor-of-bone-in-sweden-since/)
- [Treatment patterns of advanced malignant melanoma (stage III–IV) – A review of current standards in Europe](https://scholariq.org/papers/treatment-patterns-of-advanced-malignant-melanoma-stage-iii-iv-a-review-of/)
- [Antiepileptic Drugs and Suicide: A Systematic Review of Adverse Effects](https://scholariq.org/papers/antiepileptic-drugs-and-suicide-a-systematic-review-of-adverse-effects/)
- [Breast cancer recurrence, bone metastases, and visceral metastases in women with stage II and III breast cancer in Denmark](https://scholariq.org/papers/breast-cancer-recurrence-bone-metastases-and-visceral-metastases-in-women-with/)
- [Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment](https://scholariq.org/papers/preferences-for-breast-cancer-risk-reduction-among-brca1-brca2-mutation-carriers/)
- [Surgical outcomes in patients with cutaneous malignant melanoma in Europe – a systematic literature review](https://scholariq.org/papers/surgical-outcomes-in-patients-with-cutaneous-malignant-melanoma-in-europe-a/)

## Researcher topics

- [Sarcoma Diagnosis and Treatment](https://scholariq.org/topics/sarcoma-diagnosis-and-treatment/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)
- [Bone Tumor Diagnosis and Treatments](https://scholariq.org/topics/bone-tumor-diagnosis-and-treatments/)
- [Pharmacological Effects and Toxicity Studies](https://scholariq.org/topics/pharmacological-effects-and-toxicity-studies/)

## Researcher university

- [GlaxoSmithKline (United Kingdom)](https://scholariq.org/institutions/glaxosmithkline-united-kingdom/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
